Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Bisogno T et al. |
N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. |
2000 |
Biochem. J. |
pmid:11042139
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
De Petrocellis L et al. |
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. |
2000 |
FEBS Lett. |
pmid:11033355
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Klein TW et al. |
The cannabinoid system and cytokine network. |
2000 |
Proc. Soc. Exp. Biol. Med. |
pmid:10998193
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Wiley JL et al. |
Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. |
2000 |
Life Sci. |
pmid:10983852
|
Oz M et al. |
Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. |
2000 |
Eur. J. Pharmacol. |
pmid:10980258
|